Boston, MA, June 13, 2025 – Servier Pharmaceuticals, a leader in oncology committed to delivering transformative new therapies to patients, announced today that the company was included in The Boston Business Journal (BBJ) Best Places to Work list for the fifth consecutive year. This list is the BBJ’s exclusive ranking of Massachusetts companies that have built outstanding work environments.
“Being named a ‘Best Place to Work’ by Boston Business Journal for the fifth consecutive year is a true reflection on the strength of our capabilities, the caliber of our people, and the purpose that guides our work each day,” said David K. Lee, Chief Executive Officer at Servier Pharmaceuticals. “Fewer than seven years ago, Servier U.S. began in a single Boston office space with a small group of determined colleagues. Today, the organization is more than 500 strong with a singular focus – advancing science to bring transformative new therapies to patients living with cancer and rare neurologic diseases.”
BBJ’s “Best Places to Work” awards are based on anonymous surveys where employees share insights about their experiences with their employers. The survey covers company culture, benefits, opportunities for growth, mentorship support, and beyond.
“We are incredibly proud of this recognition, especially because it is based on the feedback and experiences of the Servier team,” said Nick Stefos, Head of Human Resources at Servier Pharmaceuticals. “Being selected as a winner in the Large Business category affirms that we have fostered an environment where our team members truly feel supported as they continue to advance our mission.”
Media contact
Sara Noonan I sara.noonan@servier.com
About Servier Pharmaceuticals in the U.S.
As the U.S. affiliate of the Servier Group, Servier Pharmaceuticals is focused on delivering transformative oncology and neurology medicines that fill a critical need for patients who are underserved by current therapies.
Since opening its headquarters in Boston, U.S., in 2018, Servier Pharmaceuticals quickly became a leader in cancer care and is taking bold steps to build a powerful portfolio of precision therapeutics for patients living with cancer and neurological conditions.
Governed by a non-profit foundation, Servier Group’s private corporate governance enables the company to combine its resources and global network with cutting-edge science and creativity to develop tailored solutions that drive meaningful progress for patients.
Servier is actively seeking alliances, partnerships and acquisitions across all stages of oncology and neurology research and development to accelerate the delivery of innovative treatments to patients as part of its trailblazing One Innovation Engine R&D strategy.
Servier Pharmaceuticals has been named one of the Best Places to Work by The Boston Business Journal for five consecutive years. For more information about Servier, visit Servier.us and follow Servier on LinkedIn.